
Siemens Healthineers and the Indian Institute of Science (IISc) inaugurated the Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory for AI in Precision Medicine on 24 January 2024.
Peter Schardt, Chief Technology Officer of Siemens Healthineers, inaugurated the state-of-the-art laboratory. The collaborative laboratory will develop open-source AI-based tools to precisely automate the segmentation of pathological findings in neuroimaging data, with a focus on accurately diagnosing neurological diseases and analysing their clinical impact at a population level.
The laboratory has been established with the support of Siemens Healthineers’ Corporate Social Responsibility initiative, which also includes six MTech fellowships for women, aiming to enhance female representation in artificial intelligence. Vaanathi Sundaresan, Assistant Professor at IISc’s Department of Computational and Data Sciences (CDS) will lead the programme. The focus of this collaborative laboratory will be to work closely with neurologists, radiologists and Siemens Healthineers to integrate computational models into their regular clinical workflows.
Speaking on the partnership, Peter Schardt, Chief Technology Officer, Siemens Healthineers, said, “The collaboration with IISc solidifies our commitment to advancing precision medicine through AI using state-of-the-art, data-driven deep-learning techniques. Leveraging IISc’s academic excellence and our strong core in medical imaging, smart solutions developed through this collaboration will help us ultimately save lives through precise diagnoses and evidence-based treatments.”
Govindan Rangarajan, Director, IISc, said, “This lab marks a crucial step forward in unlocking the potential of AI for precision medicine. Together, we are accelerating the future of healthcare for everyone. This collaboration is a powerful example of how industry and academia can come together to tackle complex challenges.”
Dileep Mangsuli, Executive Director, Siemens Healthineers, said, “India is one of the four global innovation hubs for Siemens Healthineers, and we are committed to being catalysts in interdisciplinary research. This laboratory is a part of our CSR initiative. We take pride in giving back to the society and healthcare research is an important aspect of it. Along with IISc, we aim to reshape the landscape of neuroscientific progress through the capabilities of artificial intelligence, translating laboratory insights into intelligent solutions. We want to empower the broader clinical research community and be changemakers in the fight against world’s most life-threatening diseases.”
Navakanta Bhat, Dean, Division of Interdisciplinary Sciences, IISc, added, “We are very excited about this partnership that offers healthcare innovation possibilities by leveraging the deep expertise of IISc faculty and students in the area of artificial intelligence along with the medical imaging expertise of Siemens Healthineers, an industry leader in this field. The focus on neuroimaging is also timely, given the growing incidence of age-related disorders of the brain. We hope that this partnership will develop new tools for early diagnosis of a variety of neurological diseases.”
The partnership between Siemens Healthineers and IISc is a milestone in artificial intelligence research in India, aiming to combat neurovascular diseases and pioneer breakthroughs in healthcare.
Media Contact
Siemens Healthineers
Shilpi Yadav
+91 99203 88209; shilpi.yadav@siemens-healthineers.com Follow the press team on X.
Visit the Siemens Healthineers Press Center.
IISc
Office of Communications
news@iisc.ac.in
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com.
The Indian Institute of Science (IISc) was established in 1909 by a visionary partnership between the industrialist Jamsetji Nusserwanji Tata, the Mysore royal family, and the Government of India. Over the last 114 years, IISc has become India’s premier institute for advanced scientific and technological research and education. Its mandate is “to provide for advanced instruction and to conduct original investigations in all branches of knowledge as are likely to promote the material and industrial welfare of India.” In 2018, IISc was selected as an Institution of Eminence (IoE) by the Government of India, and it consistently figures among the top Indian institutions in world university rankings. Further information is available at www.iisc.ac.in.
